Clopidogrel and proton pump inhibitors: can near patient testing help in the tailoring of dual antiplatelet prescription?

被引：2
|
作者：
Amoah, V.
Worrall, A. P.
Smallwood, A.
Armesilla, A. L. [2 ]
Nevill, A. M.
Cotton, J. M. [1 ]
机构：
[1] New Cross Hosp, Heart & Lung Ctr, Dept Cardiol, Wolverhampton WV10 OQP, W Midlands, England
[2] Wolverhampton Univ, Sch Appl Sci, Res Inst Healthcare Sci, Wolverhampton WV1 1DJ, W Midlands, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2010年 / 8卷 / 06期
关键词：
OMEPRAZOLE; PHARMACOKINETICS; ASPIRIN;
D O I：
10.1111/j.1538-7836.2010.03855.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1422 / 1424
页数：3
相关论文
共 50 条
  • [21] Concomitant use of proton pump inhibitors and dual antiplatelet therapy for cardiovascular outcomes
    Mandurino-Mirizzi, Alessandro
    Leonardi, Sergio
    Meloni, Chiara
    MINERVA ENDOCRINOLOGICA, 2017, 42 (03) : 228 - 237
  • [22] Diagnosing H-pylori in patients on proton pump inhibitors: A role for near patient testing?
    Robinson, RJ
    Mayberry, JF
    Wicks, ACB
    Stephens, M
    Livsey, S
    Stone, M
    GASTROENTEROLOGY, 1997, 112 (04) : A270 - A270
  • [23] The Influence of Proton Pump Inhibitors on the Antiplatelet Potency of Clopidogrel Evaluated by 5 Different Platelet Function Tests
    Gremmel, Thomas
    Steiner, Sabine
    Seidinger, Daniela
    Koppensteiner, Renate
    Panzer, Simon
    Kopp, Christoph W.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2010, 56 (05) : 532 - 539
  • [24] Aspirin/clopidogrel/ibuprofen/proton pump inhibitor interactionLow responsiveness to dual antiplatelet therapy: case report
    Reactions Weekly, 2012, 1430 (1) : 8 - 9
  • [25] Does the dual platelet antiplatelet therapy always require gastroprotection? The personalized medical indication must prevail over the indiscriminate prescription of proton pump inhibitors in patients with dual antiplatelet therapy
    Marcucci, Rossella
    GIORNALE ITALIANO DI CARDIOLOGIA, 2010, 11 (06) : 481 - 487
  • [26] Pharmaceutical and clinical implications of proton pump inhibitors with dual antiplatelet therapies: a systematic review
    Jacob J. Gries
    George Triadafilopoulos
    Hafeez Ul Hassan Virk
    Umair Khalid
    Hani Jneid
    Yochai Birnbaum
    Carl J. Lavie
    Dirk Sibbing
    Glenn N. Levine
    Chayakrit Krittanawong
    npj Gut and Liver, 2 (1):
  • [27] Appropriateness of proton pump inhibitors prescription in patient admitted to hospital: An observational study
    Gendre, P.
    Mocquard, J.
    Huon, J. F.
    ANNALES PHARMACEUTIQUES FRANCAISES, 2023, 81 (04): : 596 - 603
  • [28] Impact of proton pump inhibitors or famotidine on the antiplatelet actions during dual-antiplatelet therapy in Japanese patients
    Nagata Y.
    Inomata J.
    Kinoshita M.
    Kurokawa K.
    Aburadani I.
    Maruyama M.
    Usuda K.
    Cardiovascular Intervention and Therapeutics, 2013, 28 (1) : 22 - 29
  • [29] Safety of proton-pump inhibitors in patients on oral antiplatelet therapy with aspirin and clopidogrel after DES implantation
    Rossini, R.
    Nijaradze, T.
    Musumeci, G.
    Lettieri, C.
    Zoccai, G. Biondi
    Cicorella, N.
    Lortkipanidze, N.
    Romano, M.
    Gavazzi, A.
    Angiolillo, D. J.
    EUROPEAN HEART JOURNAL, 2009, 30 : 741 - 741
  • [30] INDIVIDUAL PROTON PUMP INHIBITORS AND OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE ON DUAL ANTIPLATELET THERAPY
    Sherwood, Matthew W.
    Melloni, Chiara
    Jones, Schuyler
    Washam, Jeffrey
    Hasselblad, Victor
    Dolor, Rowena
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A203 - A203
12345